StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)

Close on Nov 18, 2026Market cap $20.92BP/E –Yield –

BioNTech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was €2.87B, up 4.3% from the year before. The highest annual figure on record is €18.98B in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025€2.87B+4.3%
FY2024Dec 31, 2024€2.75B-28.0%
FY2023Dec 31, 2023€3.82B-77.9%
FY2022Dec 31, 2022€17.31B-8.8%
FY2021Dec 31, 2021€18.98B+3834.6%
FY2020Dec 31, 2020€482.30M+344.1%
FY2019Dec 31, 2019€108.60M-14.9%
FY2018Dec 31, 2018€127.58M+107.1%
FY2017Dec 31, 2017€61.60M–

More BioNTech figures

See a number that looks wrong?